| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,880,509 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,880,509 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
Director |
– • – |
2019-03-29 |
4 |
A |
$86.01 |
$17,460 |
D/D |
203 |
203 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
1,723 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-06-28 |
4 |
A |
$84.96 |
$20,136 |
D/D |
237 |
1,960 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-09-30 |
4 |
A |
$74.23 |
$19,745 |
D/D |
266 |
2,226 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-12-31 |
4 |
A |
$87.32 |
$20,171 |
D/D |
231 |
2,457 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-03-31 |
4 |
A |
$73.23 |
$21,017 |
D/D |
287 |
2,744 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,929 |
2,929 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2020-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,878 |
3,278 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
4,026 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-06-30 |
4 |
A |
$103.97 |
$23,809 |
D/D |
229 |
4,255 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-09-30 |
4 |
A |
$89.74 |
$23,332 |
D/D |
260 |
4,515 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-12-31 |
4 |
A |
$86.98 |
$24,441 |
D/D |
281 |
4,796 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
4,964 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-03-31 |
4 |
A |
$81.27 |
$24,218 |
D/D |
298 |
5,094 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,567 |
5,496 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
6,549 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
7,017 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-04-30 |
4 |
AS |
$222.57 |
$3,255,092 |
D/D |
(14,489) |
7,087 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-16 |
4 |
AS |
$236.94 |
$23,596,311 |
D/D |
(99,030) |
7,087 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-09-18 |
4 |
AS |
$245.00 |
$6,562,325 |
D/D |
(26,785) |
7,087 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-06-30 |
4 |
A |
$84.13 |
$23,809 |
D/D |
283 |
7,300 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-09-30 |
4 |
A |
$68.78 |
$22,078 |
D/D |
321 |
7,621 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2021-12-31 |
4 |
A |
$73.40 |
$25,176 |
D/D |
343 |
7,964 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-03-31 |
4 |
A |
$79.42 |
$25,891 |
D/D |
326 |
8,290 |
0 |
- |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
